Answers are grounded in this paper and cite their sources.
Objective This project aims to formulate nanostructured lipid carriers (NLCs) of Prochlorperazine Maleate (PCZM) to improve drug permeability. Method For the preparation of PCZM-NLCs, the High-Speed Homogenization with Ultrasonication method was utilized. The solid lipid used in this process was Dynasan 114, and the liquid lipid used was Capmul MCM. To examine the effect of the proportion of solids to liquid phospholipids, including the amount of the surfactant, on the size of the particle and efficiency of entrapment, a 3 2 -full factorial design was adopted. Result With a high desirability function of 0.906, PCZM 21 had a particle size of 178.2 ± 0.014 nm and a percentage EE of 92.79 ± 0.21. The zeta potential was −15.2 mv, which provides satisfactory stability. The TEM study reveals that the particles have a nice spherical morphology. The in-vitro and Ex-vivo have shown that NLCs provide a biphasic initial burst release followed by a sustained release that can last up to 24 h. The permeation of the drug through the Peyer’s patch was confirmed by a confocal study. All tested concentrations exhibited haemolysis percentages well below the critical safe limit of 5%, indicating biocompatibility and safety. Conclusion PCZM-NLC can act as a carrier for oral delivery to enhance medicine’s absorption and controlled release.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: